Market requirements · IS
Iceland
Iceland applies the Medicinal Products Act No. 100/2020, administered by the Icelandic Medicines Agency. Classification follows the EEA-harmonised definition, turning on presentation and intended use rather than on how a seller describes the product, and import and wholesale distribution can be carried on only under an agency licence granted after inspection of the premises. Peptide-relevant substances are additionally caught by a regime anchored to the WADA prohibited list that bans postal and courier shipment outright, which is the practical barrier a distributor meets first.
| Tell us the compounds you need for Iceland. | Ask about Iceland |
The regime
How compounds are classified in Iceland
| Governing law | The Medicinal Products Act No. 100/2020, as amended in 2020 and 2022, transposes the EEA-incorporated European pharmaceutical framework. Import of finished products and of ingredients, and their wholesale distribution, may be carried on only by a licence holder, and each licence runs for a maximum of five years. Regulation No 699/1996 sets the application content and the agency has 90 days to assess a new application. Regulation No 233/2001 on controlled substances and Regulation No 1277/2022 on import by individuals sit alongside it. |
|---|---|
| What determines classification | Iceland uses the EEA-harmonised definition, so a product is a medicinal product either by presentation or by function. The agency decides borderline cases and is also the authority for marketing authorisations, so the body that classifies also licenses. Research-use wording does not by itself remove a substance from the definition, because presentation is assessed across the whole commercial context including the website and the accompanying claims. No Icelandic guidance specific to research peptides was located, and there is no published position on the category as such. |
| EEA and Schengen, not EU | Iceland is in the European Economic Area and in Schengen and is not in the European Union. It shares its legal shape with Norway: both are EFTA states inside the EEA Agreement, both transpose the European directive rather than being bound by it directly, both are supervised by the EFTA Surveillance Authority, and in both a centralised European authorisation takes effect only after an EEA Joint Committee decision which the national agency then mirrors. Iceland is outside the EU customs union, because the EEA Agreement expressly excludes the customs union and the common commercial policy, so full customs formalities apply at the border. Schengen governs the movement of people and not of goods, so a consignment is a customs event whatever the passport rules say. |
| Prescription and controlled substances | Peptide hormones are not scheduled as narcotics: Regulation No 233/2001 classes controlled substances in its annex and no research peptide was found in those classes. The operative control is different and stricter in effect. Regulation No 1277/2022 creates a category for medicines containing substances in sections S1 and S2 of the WADA prohibited list, and for that category import by mail or courier is not permitted at all, while luggage import is capped at a 30-day supply against a prescription or dispensing label. Whether an individual peptide is prescription-only is not established as a general statement and must be checked product by product in the national product information database. |
| Enforcement posture | Active, with a dated action on point. On 2 March 2026 Iceland Revenue and Customs reported that Icelandic Customs, working with the medicines agency, the National Commissioner of Police and the Europol liaison office, seized more than 5,000 vials of illegal peptides in Europol's Operation SHIELD VI, which ran from April to November 2025 across 30 countries. Thirty-four distinct peptide types were seized, all originating in China and shipped by post and express delivery, and the customs authority stated this was the first time it had seized such peptides. It said it will continue to prioritise preventing the import of illegal medicines. |
| Already supplying Iceland? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Iceland needs settled
- Hold an import and wholesale distribution licence granted under Act No. 100/2020 before the first consignment moves, and allow 90 days plus an on-site inspection.
- Name a technical manager and a qualified person, and file their records with premises drawings, equipment and quality-system summaries as part of the application.
- Confirm that every product you intend to sell holds a marketing authorisation valid in Iceland, and do not offer anything unauthorised.
- Never move stock by post or courier to individuals, because Regulation No 1277/2022 prohibits postal import of WADA section S1 and S2 substances entirely.
- Clear every consignment as a third-country border because Iceland sits outside the EU customs union, and account for import VAT at the 24 per cent standard rate.
- Keep supplier, batch and customer records for each consignment, produce them on inspection, and re-apply with updated information at each five-year renewal.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| Ministry of Health Medicinal Products Act, No. 100/2020, as amended 2020 and 2022, English translation | 2022 consolidation | www.government.is/library/04-Legislation/Medicinal%20Produ... |
| Icelandic Medicines Agency Licences for import and wholesale distribution of medicinal products | 2021 | www.ima.is/regulated_entities/wholesalers-and-distributors... |
| Icelandic Medicines Agency Medicines in luggage and postal shipments, the WADA S1 and S2 postal prohibition | 2026 | www.ima.is/medicinal-products/medicines-in-luggage-and-pos... |
| Icelandic Medicines Agency Marketing authorisations, national, mutual recognition, decentralised and centralised routes | 2026 | www.ima.is/medicinal-products/marketing-authorisations/ |
| Iceland Revenue and Customs Large quantity of illegal peptides seized in international operation | 2026 | island.is/en/o/skatturinn/news/large-quantity-of-illegal-p... |
| European Commission, DG Trade EU trade relations with Iceland, the EEA excludes the customs union | 2026 | policy.trade.ec.europa.eu/eu-trade-relationships-country-a... |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Iceland brief as a PDF
The regime, the buyer obligations and all 6 sources, dated and linked, in one document you can forward.
Nearby
Nordics and nearby markets
Buyers supplying one of these usually supply the others. The requirements are not the same.
| Code | Market | Sources | |
|---|---|---|---|
| DK | Denmark | 5 sources | Laegemiddelstyrelsen maintains standing warnings, including on Melanotan. Rese... |
| NO | Norway | 8 sources | Norway applies the legemiddelloven and criminalises trade in listed doping sub... |
| SE | Sweden | 5 sources | Lakemedelsverket has a published position on Melanotan II, and a government-co... |
| FI | Finland | 2 sources | Fimea has warned against injectable peptides sold through social media. Semagl... |
| TR | Turkey | 6 sources | Turkey applies Law No. 1262 on Pharmaceutical and Medicinal Preparations of 19... |
| UA | Ukraine | 6 sources | Ukraine regulates medicines under the Law on Medicinal Products of 4 April 199... |
Scope
How to use this page
A summary of the published regulatory position in Iceland as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Iceland
Do you supply into Iceland?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Iceland depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Iceland. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Iceland
Tell us the compounds and your authorisations. We confirm per compound before anything ships.